237 related articles for article (PubMed ID: 15102849)
1. Pronounced diversity in electronic and chemical properties between the catalytic zinc sites of tumor necrosis factor-alpha-converting enzyme and matrix metalloproteinases despite their high structural similarity.
Solomon A; Rosenblum G; Gonzales PE; Leonard JD; Mobashery S; Milla ME; Sagi I
J Biol Chem; 2004 Jul; 279(30):31646-54. PubMed ID: 15102849
[TBL] [Abstract][Full Text] [Related]
2. X-ray absorption studies of human matrix metalloproteinase-2 (MMP-2) bound to a highly selective mechanism-based inhibitor. comparison with the latent and active forms of the enzyme.
Kleifeld O; Kotra LP; Gervasi DC; Brown S; Bernardo MM; Fridman R; Mobashery S; Sagi I
J Biol Chem; 2001 May; 276(20):17125-31. PubMed ID: 11278946
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the tumor necrosis factor-alpha-converting enzyme by its pro domain.
Gonzales PE; Solomon A; Miller AB; Leesnitzer MA; Sagi I; Milla ME
J Biol Chem; 2004 Jul; 279(30):31638-45. PubMed ID: 15100227
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2).
Rosenblum G; Meroueh SO; Kleifeld O; Brown S; Singson SP; Fridman R; Mobashery S; Sagi I
J Biol Chem; 2003 Jul; 278(29):27009-15. PubMed ID: 12679334
[TBL] [Abstract][Full Text] [Related]
5. DFT studies of the ring-opening mechanism of SB-3CT, a potent inhibitor of matrix metalloproteinase 2.
Tao P; Fisher JF; Mobashery S; Schlegel HB
Org Lett; 2009 Jun; 11(12):2559-62. PubMed ID: 19445474
[TBL] [Abstract][Full Text] [Related]
6. Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
Sawa M; Kurokawa K; Inoue Y; Kondo H; Yoshino K
Bioorg Med Chem Lett; 2003 Jun; 13(12):2021-4. PubMed ID: 12781187
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase 2 (MMP2) inhibition: DFT and QM/MM studies of the deprotonation-initialized ring-opening reaction of the sulfoxide analogue of SB-3CT.
Tao P; Fisher JF; Shi Q; Mobashery S; Schlegel HB
J Phys Chem B; 2010 Jan; 114(2):1030-7. PubMed ID: 20039633
[TBL] [Abstract][Full Text] [Related]
8. A comparison of the binding sites of matrix metalloproteinases and tumor necrosis factor-alpha converting enzyme: implications for selectivity.
Lukacova V; Zhang Y; Kroll DM; Raha S; Comez D; Balaz S
J Med Chem; 2005 Apr; 48(7):2361-70. PubMed ID: 15801829
[TBL] [Abstract][Full Text] [Related]
9. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
10. The TACE zymogen: re-examining the role of the cysteine switch.
Milla ME; Gonzales PE; Leonard JD
Cell Biochem Biophys; 2006; 44(3):342-8. PubMed ID: 16679521
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.
Ye Y; Kuang X; Xie Z; Liang L; Zhang Z; Zhang Y; Ma F; Gao Q; Chang R; Lee HH; Zhao S; Su J; Li H; Peng J; Chen H; Yin M; Peng C; Yang N; Wang J; Liu J; Liu H; Han L; Chen X
Genome Med; 2020 Sep; 12(1):83. PubMed ID: 32988398
[TBL] [Abstract][Full Text] [Related]
12. Design strategies for the identification of MMP-13 and Tace inhibitors.
Skotnicki JS; DiGrandi MJ; Levin JI
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):742-59. PubMed ID: 14579524
[TBL] [Abstract][Full Text] [Related]
13. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.
Amour A; Slocombe PM; Webster A; Butler M; Knight CG; Smith BJ; Stephens PE; Shelley C; Hutton M; Knäuper V; Docherty AJ; Murphy G
FEBS Lett; 1998 Sep; 435(1):39-44. PubMed ID: 9755855
[TBL] [Abstract][Full Text] [Related]
14. The active site of a zinc-dependent metalloproteinase influences the computed pK(a) of ligands coordinated to the catalytic zinc ion.
Cross JB; Duca JS; Kaminski JJ; Madison VS
J Am Chem Soc; 2002 Sep; 124(37):11004-7. PubMed ID: 12224947
[TBL] [Abstract][Full Text] [Related]
15. Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.
Lee MH; Dodds P; Verma V; Maskos K; Knäuper V; Murphy G
Biochem J; 2003 Apr; 371(Pt 2):369-76. PubMed ID: 12556225
[TBL] [Abstract][Full Text] [Related]
16. Drosophila TIMP is a potent inhibitor of MMPs and TACE: similarities in structure and function to TIMP-3.
Wei S; Xie Z; Filenova E; Brew K
Biochemistry; 2003 Oct; 42(42):12200-7. PubMed ID: 14567681
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis.
Zhang Y; Xu J; Levin J; Hegen M; Li G; Robertshaw H; Brennan F; Cummons T; Clarke D; Vansell N; Nickerson-Nutter C; Barone D; Mohler K; Black R; Skotnicki J; Gibbons J; Feldmann M; Frost P; Larsen G; Lin LL
J Pharmacol Exp Ther; 2004 Apr; 309(1):348-55. PubMed ID: 14718605
[TBL] [Abstract][Full Text] [Related]
18. Comparison of properties of tumor necrosis factor-alpha converting enzyme (TACE) and some matrix metalloproteases (MMPs) in catalytic domains.
Zhao Y; Feng W; Yang Y; Ling L; Chen R
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(6):637-9. PubMed ID: 17357475
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ
Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
[TBL] [Abstract][Full Text] [Related]
20. Discovery of N-hydroxy-2-(2-oxo-3-pyrrolidinyl)acetamides as potent and selective inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).
Duan JJ; Lu Z; Xue CB; He X; Seng JL; Roderick JJ; Wasserman ZR; Liu RQ; Covington MB; Magolda RL; Newton RC; Trzaskos JM; Decicco CP
Bioorg Med Chem Lett; 2003 Jun; 13(12):2035-40. PubMed ID: 12781190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
